Non-invasive edge MaxPlay focuses on saliva-based biosensors for athletic performance and healthspan, presenting a non-invasive value proposition that can be positioned to athletic brands, sports teams, and wellness programs seeking easier biomarker monitoring.

Lean team leverage With a small team and early-stage funding, there is an opportunity to position partnerships with larger CROs, contract manufacturers, or enterprise wellness platforms to scale go-to-market efforts without proportional headcount increases.

Sports performance market Target the rapidly evolving athletic performance segment, aligning with sports academies, professional leagues, and fitness tech platforms that monetize performance analytics and personalized training plans.

Digital infrastructure Existing tech stack including cloud, CDN, and payment capabilities suggests readiness for B2B2C or B2B2B partnerships; propose integrations with fitness apps, wearables, and subscription services to capture recurring revenue.

Funding and growth With initial funding of around one million and revenue in the low range, highlight opportunities for co-development ventures, strategic investment, or sponsorships with larger biotech or consumer health companies seeking early-stage innovation.